SAMORITA HOSPITAL LIMITED Financials Samorita Hospital Limited
Equities
SAMORITA
BD0553SMHOS8
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 70.4 BDT | -0.98% |
|
+2.03% | -11.34% |
Valuation
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 1,391 | 1,239 | 1,144 | 1,268 | 1,387 | 1,478 |
| Enterprise Value (EV) 1 | 1,292 | 1,113 | 1,077 | 1,218 | 1,378 | 1,476 |
| P/E ratio | 58.9 x | 38.4 x | 352 x | 30.1 x | 85.2 x | 2,052 x |
| Yield | 1.55% | 1.45% | - | 1.49% | 0.68% | - |
| Capitalization / Revenue | 3.76 x | 3.31 x | 3.56 x | 3.22 x | 4.1 x | 4.42 x |
| EV / Revenue | 3.49 x | 2.97 x | 3.35 x | 3.09 x | 4.08 x | 4.42 x |
| EV / EBITDA | 24.6 x | 19.1 x | 41.7 x | 17.8 x | 31.1 x | 55 x |
| EV / FCF | 99.4 x | 31.5 x | -23.7 x | -31.1 x | -68.6 x | 52,396 x |
| FCF Yield | 1.01% | 3.18% | -4.23% | -3.22% | -1.46% | 0% |
| Price to Book | 1.49 x | 1.31 x | 1.23 x | 1.31 x | 1.43 x | 1.54 x |
| Nbr of stocks (in thousands) | 21,801 | 21,801 | 21,801 | 21,801 | 21,801 | 21,801 |
| Reference price 2 | 63.82 | 56.81 | 52.47 | 58.18 | 63.64 | 67.82 |
| Announcement Date | 26/11/18 | 08/12/19 | 03/12/20 | 02/12/21 | 01/12/22 | 08/11/23 |
1BDT in Million2BDT
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 370.2 | 374.4 | 321.2 | 393.6 | 338.1 | 334.3 |
| EBITDA 1 | 52.52 | 58.18 | 25.85 | 68.29 | 44.27 | 26.82 |
| EBIT 1 | 29.89 | 36.85 | 5.888 | 47.65 | 24.41 | 3.782 |
| Operating Margin | 8.07% | 9.84% | 1.83% | 12.11% | 7.22% | 1.13% |
| Earnings before Tax (EBT) 1 | 34.2 | 43.72 | 10.28 | 54.53 | 24.34 | 3.1 |
| Net income 1 | 23.62 | 32.24 | 3.253 | 42.09 | 16.29 | 0.7204 |
| Net margin | 6.38% | 8.61% | 1.01% | 10.69% | 4.82% | 0.22% |
| EPS 2 | 1.083 | 1.479 | 0.1492 | 1.931 | 0.7473 | 0.0330 |
| Free Cash Flow 1 | 13 | 35.37 | -45.53 | -39.21 | -20.09 | 0.0282 |
| FCF margin | 3.51% | 9.45% | -14.17% | -9.96% | -5.94% | 0.01% |
| FCF Conversion (EBITDA) | 24.74% | 60.8% | - | - | - | 0.11% |
| FCF Conversion (Net income) | 55.03% | 109.71% | - | - | - | 3.91% |
| Dividend per Share 2 | 0.9895 | 0.8246 | - | 0.8658 | 0.4329 | - |
| Announcement Date | 26/11/18 | 08/12/19 | 03/12/20 | 02/12/21 | 01/12/22 | 08/11/23 |
1BDT in Million2BDT
Estimates
Balance Sheet Analysis
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 99 | 125 | 66.7 | 50.8 | 8.83 | 2.04 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | 13 | 35.4 | -45.5 | -39.2 | -20.1 | 0.03 |
| ROE (net income / shareholders' equity) | 2.64% | 3.43% | 0.35% | 4.43% | 1.68% | 0.07% |
| ROA (Net income/ Total Assets) | 1.84% | 2.23% | 0.36% | 2.77% | 1.36% | 0.21% |
| Assets 1 | 1,285 | 1,449 | 913.2 | 1,519 | 1,201 | 337.1 |
| Book Value Per Share 2 | 42.80 | 43.30 | 42.60 | 44.60 | 44.40 | 44.00 |
| Cash Flow per Share 2 | 4.540 | 2.530 | 1.220 | 3.090 | 3.190 | 2.040 |
| Capex 1 | 26.1 | 8.33 | 60.4 | 81.7 | 46.2 | 26.5 |
| Capex / Sales | 7.05% | 2.22% | 18.8% | 20.75% | 13.68% | 7.94% |
| Announcement Date | 26/11/18 | 08/12/19 | 03/12/20 | 02/12/21 | 01/12/22 | 08/11/23 |
1BDT in Million2BDT
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -11.34% | 13.09M | |
| -18.52% | 16.2B | |
| +5.41% | 12.73B | |
| +3.98% | 11.68B | |
| +4.36% | 10.22B | |
| +28.07% | 8.6B | |
| -4.98% | 7.78B | |
| +6.76% | 6.73B | |
| +7.33% | 6.4B | |
| +48.17% | 4.49B |
- Stock Market
- Equities
- SAMORITA Stock
- Financials Samorita Hospital Limited